Showing results (821-830 of 835) with videos related to
Sort By:
Pageof 84
The Journal of General Virology|June 16, 2021
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United KingdomJoseph G Chappell, Theocharis Tsoleridis, Gemma Clark, et al.Scientific Reports|August 24, 2017
Treating the placenta to prevent adverse effects of gestational hypoxia on fetal brain developmentTom J Phillips, Hannah Scott, David A Menassa, et al.Nature Biomedical Engineering|April 7, 2019
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse modelsWalid S Kamoun, Dmitri B Kirpotin, Zhaohua Richard Huang, et al.Proceedings. Biological Sciences|March 17, 2026
Evidence for latitude-driven changes in diel rhythms in a wide-ranging seabirdNatasha Gillies, Sebastien Descamps, Nicholas Per Huffeldt, et al.European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancerSteven G DuBois, Lucas Moreno, Rochelle Bagatell, et al.Experimental Neurology|May 14, 2014
Secretions from placenta, after hypoxia/reoxygenation, can damage developing neurones of brain under experimental conditionsDaniel J Curtis, Aman Sood, Tom J Phillips, et al.Science Advances|November 5, 2020
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.The Journal of Clinical Investigation|September 5, 2018
Mutations in multiple components of the nuclear pore complex cause nephrotic syndromeDaniela A Braun, Svjetlana Lovric, David Schapiro, et al.Cell Reports|November 7, 2019
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial DesignJo Lynne Rokita, Komal S Rathi, Maria F Cardenas, et al.Pageof 84